FINCoVac 2.0

N/A

Report date: 2025/01/26 16:30:17

Base Information

Drug NameFINCoVac 2.0
Drug Alias NameSARS-CoV-2 vaccine (Rokote Laboratories Finland)adenovirus type 5 vector vaccine (Rokote Laboratories Finland)Ad5-based COVID-19 vaccine (Rokote Laboratories Finland)recombinant adenovirus vector vaccine (Rokote Laboratories Finland)COVID-19 vaccine (Rokote Laboratories Finland) +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Helsinki
China Registration ClassN/A

Develop Information

Active CompaniesRokote Laboratories Finland Ltd
Inactive CompaniesUniversity Of HelsinkiUniversity Of Eastern Finland
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A